JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
1-Year Return
109.69%
This Quarter Return
-12.41%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$161M
AUM Growth
+$135M
(+506%)
Cap. Flow
+$134M
Cap. Flow
% of AUM
83.31%
Top 10 Holdings %
Top 10 Hldgs %
83.74%
Holding
67
New
22
Increased
4
Reduced
23
Closed
18
Top Buys
| 1 |
Mercado Libre
MELI
|
$37.4M |
| 2 |
StoneCo
STNE
|
$25.7M |
| 3 |
XP
XP
|
$21.7M |
| 4 |
PagSeguro Digital
PAGS
|
$14M |
| 5 |
LUXE
LuxExperience B.V. American Depositary Shares, each representing one Ordinary Share
LUXE
|
$11.3M |
Top Sells
| 1 |
Microsoft
MSFT
|
$1.87M |
| 2 |
Thermo Fisher Scientific
TMO
|
$1.25M |
| 3 |
iShares Biotechnology ETF
IBB
|
$1.04M |
| 4 |
Apple
AAPL
|
$796K |
| 5 |
Intuitive Surgical
ISRG
|
$659K |
Sector Composition
| 1 | Consumer Discretionary | 30.69% |
| 2 | Technology | 24.6% |
| 3 | Financials | 17.23% |
| 4 | Healthcare | 12.26% |
| 5 | Communication Services | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Eli Lilly
LLY
$663B
| $466K | 0.29% |
2,494
+448
| +22% | +$83.7K |
|
27
Acadia Pharmaceuticals
ACAD
$4.31B
| $451K | 0.28% |
+17,472
| New | +$451K |
|
28
Stryker
SYK
$151B
| $451K | 0.28% |
1,850
-1,146
| -38% | -$279K |
|
29
Amazon
AMZN
$2.49T
| $449K | 0.28% |
+2,900
| New | +$449K |
|
30
Becton Dickinson
BDX
$54.4B
| $448K | 0.28% |
1,887
-1,931
| -51% | -$458K |
|
31
Cigna
CI
$80.8B
| $381K | 0.24% |
1,575
-648
| -29% | -$157K |
|
32
Humana
HUM
$37.5B
| $378K | 0.23% |
901
-133
| -13% | -$55.8K |
|
33
argenx
ARGX
$44.8B
| $369K | 0.23% |
1,339
-520
| -28% | -$143K |
|
34
Amgen
AMGN
$152B
| $354K | 0.22% |
1,423
-836
| -37% | -$208K |
|
35
Agilent Technologies
A
$36B
| $350K | 0.22% |
2,749
-1,887
| -41% | -$240K |
|
36
Centene
CNC
$14B
| $341K | 0.21% |
5,343
-1,745
| -25% | -$111K |
|
37
Walt Disney
DIS
$213B
| $332K | 0.21% |
+1,800
| New | +$332K |
|
38
Expedia Group
EXPE
$26.4B
| $327K | 0.2% |
+1,900
| New | +$327K |
|
39
AbbVie
ABBV
$376B
| $317K | 0.2% |
2,925
-1,709
| -37% | -$185K |
|
40
AstraZeneca
AZN
$254B
| $309K | 0.19% |
6,215
-1,062
| -15% | -$52.8K |
|
41
Ascendis Pharma
ASND
$12.1B
| $300K | 0.19% |
2,331
-1,188
| -34% | -$153K |
|
42
HCA Healthcare
HCA
$97B
| $294K | 0.18% |
1,562
-1,502
| -49% | -$283K |
|
43
Exact Sciences
EXAS
$9.76B
| $293K | 0.18% |
2,223
-1,264
| -36% | -$167K |
|
44
Regeneron Pharmaceuticals
REGN
$60.1B
| $290K | 0.18% |
613
-279
| -31% | -$132K |
|
45
Elevance Health
ELV
$69.9B
| $261K | 0.16% |
726
-508
| -41% | -$183K |
|
46
Hologic
HOLX
$14.6B
| $252K | 0.16% |
3,383
-1,916
| -36% | -$143K |
|
47
BioMarin Pharmaceuticals
BMRN
$10.9B
| $235K | 0.15% |
3,109
-2,009
| -39% | -$152K |
|
|
XLRN
48
DELISTED
Acceleron Pharma Inc.
XLRN
| $234K | 0.15% |
1,725
+7
| +0.4% | +$950 |
|
|
AMRN
49
Amarin Corp
AMRN
$304M
| $77K | 0.05% |
+619
| New | +$77K |
|
|
50
Apple
AAPL
$3.52T
| – | – |
-6,000
| Closed | -$796K |
|